Mutations in the gene for the common gamma chain (γc) in X-linked severe combined immunodeficiency

1998 ◽  
Vol 103 (6) ◽  
pp. 730-731 ◽  
Author(s):  
Sebastian D. Fugmann ◽  
Susanna Müller ◽  
Wilhelm Friedrich ◽  
Claus R. Bartram ◽  
K. Schwarz
Keyword(s):  
Severe Combined Immunodeficiency ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Common Gamma Chain ◽  
The Common

A novel splice-site mutation in the common gamma chain (?c) geneIL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype

2004 ◽  
Vol 23 (5) ◽  
pp. 522-523 ◽  
Author(s):  
Samantha L. Ginn ◽  
Christine Smyth ◽  
Melanie Wong ◽  
Bruce Bennetts ◽  
Peter B. Rowe ◽  
...  
Keyword(s):  
Splice Site ◽  
Severe Combined Immunodeficiency ◽  
Splice Site Mutation ◽  
Combined Immunodeficiency ◽  
Site Mutation ◽  
Gamma Chain ◽  
Common Gamma Chain ◽  
The Common

Interleukin-2 receptor common gamma chain (IL2RG) defects present a diagnostic challenge

2018 ◽  
Vol 5 (4) ◽  
pp. 130-134
Author(s):  
Caroline Weisser ◽  
Dennis E. Bulman ◽  
Kayla Flamenbaum ◽  
Maian Roifman
Keyword(s):  
Genetic Analysis ◽  
Severe Combined Immunodeficiency ◽  
Genetic Defect ◽  
Interleukin 2 ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Gene Encoding ◽  
Common Gamma Chain ◽  
Interleukin 2 Receptor ◽  
The Common

Background: The protein encoded by interleukin-2 receptor common gamma chain (IL2RG) is an important signaling component of many interleukin receptors, including those of interleukin-2, -4, -7, and -21, known as the common gamma chain. Mutations in the gene encoding the common gamma chain of the interleukin-2 receptor cause X-linked severe combined immunodeficiency (SCID). In this report, we present an unknown genetic defect of a patient diagnosed with SCID whose genetic analysis was performed 2 decades later. Methods: Whole genome sequencing and Sanger confirmation were used to identify a novel frameshift mutation in IL2RG. Massively parallel sequencing of genes associated with SCID were performed on the patient’s mother and sister. Results: Next generation sequencing techniques identified a heterozygous frame-shift deletion in the gene encoding the common gamma chain of IL2RG in our patient. The patient’s mother had a low level mosaicism for the same deletion. The sister had no detectable deletion. Conclusion: We have identified a novel mutation in IL2RG resulting in an X-linked SCID phenotype. The genetic analysis of the patient’s mother revealed a mosaicism which was not passed on to his sister. The importance of genetic analysis in family members and SCID patients with an unknown genetic defect should be emphasized for family planning and subsequent genetic counseling. Statement of novelty: Genetic testing is an extremely important component in evaluating severe combined immunodeficiency as it impacts treatment course and prognosis, and allows for genetic analysis and counselling of family members.

Suspected Atypical Common Gamma Chain Severe Combined Immunodeficiency

2006 ◽  
Vol 117 (2) ◽  
pp. S288
Author(s):  
A. Chandra ◽  
D. Webster ◽  
K.C. Gilmour ◽  
D.S. Kumararatne ◽  
A. Thrasher
Keyword(s):  
Severe Combined Immunodeficiency ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Common Gamma Chain

scholarly journals Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency

Blood ◽  
2007 ◽  
Vol 110 (1) ◽  
pp. 67-73 ◽  
Author(s):  
Javier Chinen ◽  
Joie Davis ◽  
Suk See De Ravin ◽  
Beverly N. Hay ◽  
Amy P. Hsu ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cell Function ◽  
Severe Combined Immunodeficiency ◽  
Marrow Transplant ◽  
Salvage Treatment ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Gene Encoding ◽  
Il2rg Gene ◽  
The Common

Retroviral gene therapy can restore immunity to infants with X-linked severe combined immunodeficiency (XSCID) caused by mutations in the IL2RG gene encoding the common gamma chain (γc) of receptors for interleukins 2 (IL-2), −4, −7, −9, −15, and −21. We investigated the safety and efficacy of gene therapy as salvage treatment for older XSCID children with inadequate immune reconstitution despite prior bone marrow transplant from a parent. Subjects received retrovirus-transduced autologous peripherally mobilized CD34+ hematopoietic cells. T-cell function significantly improved in the youngest subject (age 10 years), and multilineage retroviral marking occurred in all 3 children.

A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T−NK−B+)

2015 ◽  
Vol 67 (11-12) ◽  
pp. 629-639 ◽  
Author(s):  
Weiping Tan ◽  
Sifei Yu ◽  
Jiaying Lei ◽  
Baojing Wu ◽  
Changyou Wu
Keyword(s):  
Severe Combined Immunodeficiency ◽  
Chinese Family ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Common Gamma Chain

scholarly journals Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.

1995 ◽  
Vol 95 (3) ◽  
pp. 1169-1173 ◽  
Author(s):  
F C Schmalstieg ◽  
W J Leonard ◽  
M Noguchi ◽  
M Berg ◽  
H E Rudloff ◽  
...  
Keyword(s):  
Missense Mutation ◽  
Chain Gene ◽  
Combined Immunodeficiency ◽  
Gamma Chain ◽  
Common Gamma Chain ◽  
The Common
Sign in / Sign up

Export Citation Format

Share Document